Craig-Hallum raised the firm’s price target on Koru Medical (KRMD) to $5 from $4 and keeps a Buy rating on the shares. The firm notes Koru Medical reported Q3 ahead of expectations, with guidance raised and importantly, cash flow breakeven reiterated for Q4.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD: